Abstract
Anecortave acetate is a unique ocular angiostatic cortisene that has broad-based anti-angiogenic activity in 14 different preclinical models of neovascularization, across multiple species and inducers of neovascularization. Anecortave acetate is being tested clinically for inhibition of choroidal neovascularization associated with age-related macular degeneration.
Original language | English |
---|---|
Pages (from-to) | S41-S48 |
Journal | Survey of Ophthalmology |
Volume | 52 |
Issue number | 1 SUPPL. |
DOIs | |
State | Published - 1 Jan 2007 |
Keywords
- age-related macular degeneration
- anecortave acetate
- choroidal neovascularization
- efficacy
- preclinical